Veeda Clinical Research Pvt Ltd
We are one of the largest Independent CROs in India with a scientific edge, technical skills and better foresight for BA BE Studies & Clinical trials; with an objective of becoming a catalyst for enhanced drug developments to facilitate better patient treatments.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
How to enable each healthcare professional to fully understand your product
White Papers and Resources | September 7, 2016 | Anthill Agency
Read these three articles to understand how working at an individual level benefits all customers:
Alzheimer’s disease: reviewing the immediate treatment horizon
White Papers and Resources | September 1, 2016 | Blue Latitude Health
Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.
A stumble, but not a fall – what’s next for Opdivo?
White Papers and Resources | August 25, 2016 | Blue Latitude Health
Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results.
Meet Anthill at conferences in London
White Papers and Resources | August 19, 2016 | Anthill Agency
October, the month of multichannel pharma marketing in London. Meet us at DigiPharm and Multichannel Excellence Summit
Immuno-oncology; bringing patients closer to treatment
White Papers and Resources | August 18, 2016 | Blue Latitude Health
What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment?
Therapy Watch market snapshots
White Papers and Resources | August 12, 2016 | Inizio
Therapy Watch is a ‘real-time’ syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed,...
Case Study: Private market opportunity for a travel vaccine
White Papers and Resources | August 12, 2016 | Inizio
Our client needed exploratory research to determine the global opportunity for a new travel vaccine in the private market. It was crucial to determine:Which markets had the highest potential to...
Infographic: Conference Live
White Papers and Resources | August 12, 2016 | Inizio
Conference Live gives you real-time insights, utilising the multimedia functionality of the smartphone in an innovative mobile app methodology. We conduct mobile conference research amongst physicians attending conferences, giving our clients...
Blog: The Cost of Counterfeits
White Papers and Resources | August 12, 2016 | Inizio
The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.
Video: Self-pay and Emerging Markets
White Papers and Resources | August 12, 2016 | Inizio
A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public...